Search results for "dron"

showing 10 items of 4363 documents

Octahedral distortion caused by hydrogen bonding in tris(diethylammonium) hexachloridoantimonate(III).

2010

The factors influencing the distortion of inorganic anions in the structures of chloridoantimonates(III) with organic cations, in spite of numerous structural studies on those compounds, have not been clearly described and separated. The title compound, [(C(2)H(5))(2)NH(2)](3)[SbCl(6)], consisting of isolated distorted [SbCl(6)](3-) octahedra that have C(3) symmetry and [(C(2)H(5))(2)NH(2)](+) cations, unequivocally shows the role played by hydrogen bonding in the geometry variations of inorganic anions. The organic cations, which are linked to the inorganic substructure through N-H...Cl hydrogen bonds, are clearly responsible for the distortion of the octahedral coordination of Sb(III) in …

Bond lengthTrischemistry.chemical_compoundCrystallographychemistryOctahedronHydrogen bondDistortionInorganic chemistrySubstructureGeneral MedicineCrystal structureGeneral Biochemistry Genetics and Molecular BiologyActa crystallographica. Section C, Crystal structure communications
researchProduct

Diisopropyl [(2-hydroxy-1-naphthyl)methyl]phosphonate

2003

The bond lengths and angles in the title compound, C17H23PO4, are in accordance with anticipated values. There are two conformers in the asymmetric unit. They differ from each other in the orientation of the C and P tetrahedra. Analysis of the structure does not reveal any significant differences between the bond distances and angles of the mol­ecules in the asymmetric unit. In the crystal structure, the conformers are linked by O—H⋯O=P and C—H⋯O hydrogen bonds.

Bond lengthchemistry.chemical_compoundCrystallographyStereochemistryChemistryHydrogen bondTetrahedronGeneral Materials ScienceGeneral ChemistryCrystal structureCondensed Matter PhysicsConformational isomerismPhosphonateActa Crystallographica Section E Structure Reports Online
researchProduct

One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost-benefit evalu…

2022

Antiresorptive drugs (bisphosphonates and denosumab) have become the cornerstone of medical supportive treatment of bone metastases in solid cancer patients. In the beginning, the choice of available antiresorptive agents was limited to bisphosphonates and the treatment options restricted principally to monthly pamidronate and monthly zoledronic acid. Introduction of new antiresorptive therapies (monthly denosumab) and schedules (zoledronic acid every 3 months, upfront or after initial period of monthly infusion) in the last decade increased the range of available options, thus challenging treatment decision making. Direct and indirect costs of very different treatment options are difficult…

Bone Density Conservation AgentsDiphosphonatesOsteonecrosis of the jawZoledronic acid; Denosumab; Bone metastases; Solid cancer; Osteonecrosis of the jaw; MRONJCost-Benefit AnalysisBone metastasesSolid cancerPamidronateBone NeoplasmsMRONJRisk AssessmentOncologyQuality of LifeHumansBisphosphonate-Associated Osteonecrosis of the JawDenosumabZoledronic acid
researchProduct

Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review

2015

Introduction: Orthodontic anchorage is one of the most challenging aspects of Orthodontics. Preventing undesired movement of teeth could result in safer and less complicated orthodontic treatment. Recently, several reviews have been published about the effects of different molecules on bone physiology and the clinical side effects in Orthodontics. However, the effects of local application of these substances on the rate of orthodontic tooth movement have not been assessed.Objectives: The aim of this research was to analyze the scientific evidence published in the literature about the effects of different molecules on orthodontic anchorage.Methods: The literature was systematically reviewed …

Bone remodeling periodBisfosfonatosTooth Movement TechniquesMovimentação dentáriaPharmacological managementAnti-Inflammatory AgentsOsteoclastsPamidronateDentistryZoledronic AcidAntioxidantsLactonesMiceStilbenesOrthodontic Anchorage ProceduresMedicineAgentes anti-inflamatóriosSulfonesAnti-inflammatory agentsOrthodonticsDiphosphonatesOsteoprotegerinaImidazolesOrthodontic anchorage proceduresArticlesBisphosphonatesProcedimentos de ancoragem ortodônticaTooth movementInclusion and exclusion criteriaBone RemodelingTooth MobilityOral SurgeryDiclofenacMEDLINEOrthodonticsKappa indexInterferon-gammaAnimalsHumansbusiness.industryOsteoprotegerinBone physiologyIsoxazolesOrthodontic Anchorage ProceduresAcetylcysteineRatslcsh:RK1-715CelecoxibResveratrolTooth movementlcsh:DentistryClodronic Acidbusiness
researchProduct

A neutron source for IGISOL-JYFLTRAP : Design and characterisation

2017

A white neutron source based on the Be(p, nx) reaction for fission studies at the IGISOL-JYFLTRAP facility has been designed and tested. 30MeV protons impinge on a 5mm thick water-cooled beryllium disc. The source was designed to produce at least 1012 fast neutrons/s on a secondary fission target, in order to reach competitive production rates of fission products far from the valley of stability. The Monte Carlo codes MCNPX and FLUKA were used in the design phase to simulate the neutron energy spectra. Two experiments to characterise the neutron field were performed: the first was carried out at The Svedberg Laboratory in Uppsala (SE), using an Extended-Range Bonner Sphere Spectrometer and …

Bonner spherePhysicsNuclear and High Energy Physics010308 nuclear & particles physicsFissionHadronNuclear Theorychemistry.chemical_element01 natural sciencesNuclear physicsSubatomär fysikchemistry0103 physical sciencesSubatomic PhysicsPhysics::Accelerator PhysicsNeutron sourceNuclear fusionneutron sourcesPhysics::Atomic PhysicsBeryllium010306 general physicsNuclear Experiment
researchProduct

New phosphathiamacrocycles containing polypypiridine units

2006

Abstract A new 2,2′-bipyridine-based phosphadithiamacrocycle: 3,3′-5-phenyl-2,8-dithia-5-phospha[9]-2,2′-bipyridinophane (L) has been synthesized by reacting 6,6′-bis(bromomethyl)-2,2′-bipyridine and dilithium 3-phenyl-3-phosphapenta-1,5-dithiolate. The phosphoryl derivative: 3,3′-5-oxo-5-phenyl-2,8-dithia-5-phospha[9]-2,2′-bipyridinophane (Lox) synthesized by direct oxidation of L at open atmosphere. Both compounds have been isolated as white solids containing different amounts of LiBr. The reaction of acetonitrile solutions of these solids with Fe(II) perchlorate gave the complexes [FeBr(L)](ClO4) · 2H2O and [FeBr(Lox)](ClO4) · 3H2O, which were crystallized as [FeBr(L)]Br · H2O and [ FeBr…

BromineDenticityNitromethane010405 organic chemistryChemistryLigandStereochemistrychemistry.chemical_element010402 general chemistry01 natural sciencesMedicinal chemistry0104 chemical sciencesInorganic ChemistryDilithiumchemistry.chemical_compoundPerchlorateOctahedronMaterials ChemistryPhysical and Theoretical ChemistryAcetonitrilePolyhedron
researchProduct

Multi-channel search for squarks and gluinos in root s=7 TeV pp collisions with the ATLAS detector at the LHC

2013

A search for supersymmetric particles in final states with zero, one, and two leptons, with and without jets identified as originating from b-quarks, in 4.7 fb[superscript −1] of √s = 7 TeV pp collisions produced by the Large Hadron Collider and recorded by the ATLAS detector is presented. The search uses a set of variables carrying information on the event kinematics transverse and parallel to the beam line that are sensitive to several topologies expected in supersymmetry. Mutually exclusive final states are defined, allowing a combination of all channels to increase the search sensitivity. No deviation from the Standard Model expectation is observed. Upper limits at 95 % confidence level…

Brookhaven National LaboratoryParticle physicsPhysics and Astronomy (miscellaneous)Supergauge TransformationsContext (language use)ddc:500.253001 natural sciencesStandard ModelSet (abstract data type)CurrentsPions0103 physical sciencesddc:530Sensitivity (control systems)WeakHigh Energy Physics010306 general physicsEngineering (miscellaneous)QCCiencias ExactasPhysicsproton–proton collisionsHadron-Hadron ScatteringLarge Hadron ColliderATLAS detector010308 nuclear & particles physicsSettore FIS/01 - Fisica SperimentaleHigh Energy Physics::PhenomenologyFísicaSupersymmetryATLASgluinosHADRON-HADRON COLLISIONSExperimental High Energy PhysicsComputingMethodologies_DOCUMENTANDTEXTPROCESSINGsquarksHigh Energy Physics::ExperimentSupersymmetryLHCEvent (particle physics)LeptonModel
researchProduct

Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications.

2007

Abstract The clinical significance of serum cathepsin K and cystatin C was assessed in patients with breast cancer (BCa) or prostate cancer (PCa) with confined disease (M0) or bone metastasis (BM). Cathepsin K and cystatin C circulating levels were determined by ELISAs in 63 cancer patients, in 35 patients with nonmalignant diseases and in 42 healthy blood donors (control group). In BCa patients, cathepsin K serum levels were significantly lower than in sex matched control group (HS; p  = 0.0008) or in patients with primary osteoporosis (OP; p  = 0.0009). On the contrary, cystatin C levels were significantly higher in BCa patients than in HS ( p  = 0.0001) or OP ( p  = 0.017). In PCa patien…

CA15-3Malemedicine.medical_specialtyCathepsin KProstatic HyperplasiaBone NeoplasmsBreast NeoplasmsEnzyme-Linked Immunosorbent Assayurologic and male genital diseasesZoledronic AcidProstate cancerInternal medicinemedicineCathepsin KBiomarkers TumorHumansCystatin CAgedPharmacologyAged 80 and overbiologyBone Density Conservation AgentsDiphosphonatesbusiness.industryBone cancerImidazolesCancerBone metastasisProstatic NeoplasmsGeneral MedicineMiddle Agedmedicine.diseaseCathepsinsCystatinsBone metastasis; cathepsin K; Cystatin CEndocrinologyZoledronic acidCystatin CROC CurveBone metastasiCase-Control Studiesbiology.proteinDisease ProgressionOsteoporosisFemaleDrug Monitoringbusinessmedicine.drugBiomedicinepharmacotherapy = Biomedecinepharmacotherapie
researchProduct

Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases

2013

Studies in preclinical models have demonstrated the superior anti-tumor effect of CpG oligodeoxynucleotides (CpG-ODN) when administered at the tumor site rather than systemically. We evaluated the effect of aerosolized CpG-ODN on lung metastases in mice injected with immunogenic N202.1A mammary carcinoma cells or weakly immunogenic B16 melanoma cells. Upon reaching the bronchoalveolar space, aerosolized CpG-ODN activated a local immune response, as indicated by production of IL-12p40, IFN-γ and IL-1β and by recruitment and maturation of DC cells in bronchoalveolar lavage fluid of mice. Treatment with aerosolized CpG-ODN induced an expansion of CD4+ cells in lung and was more efficacious tha…

CD4-Positive T-LymphocytesLung NeoplasmsInterleukin-1betaMelanoma ExperimentalAntineoplastic AgentsInterferon-gammaMiceCell Line TumorAnimalsHumansNeoplasm MetastasisAerosolsInterleukin-12 Subunit p40cpg-odnlung cancer microenvironment inflammationlung metastasesDendritic CellsGene Expression Regulation NeoplasticMice Inbred C57BLOligodeoxyribonucleotidesFemaleaerosol deliveryClodronic Acidaerosol delivery; cpg-odn; lung metastases; miceImmunosuppressive AgentsNeoplasm Transplantation
researchProduct

Transverse-momentum-dependent Multiplicities of Charged Hadrons in Muon-Deuteron Deep Inelastic Scattering

2017

A semi-inclusive measurement of charged hadron multiplicities in deep inelastic muon scattering off an isoscalar target was performed using data collected by the COMPASS Collaboration at CERN. The following kinematic domain is covered by the data: photon virtuality $Q^{2}>1$ (GeV/$c$)$^2$, invariant mass of the hadronic system $W > 5$ GeV/$c^2$, Bjorken scaling variable in the range $0.003 < x < 0.4$, fraction of the virtual photon energy carried by the hadron in the range $0.2 < z < 0.8$, square of the hadron transverse momentum with respect to the virtual photon direction in the range 0.02 (GeV/$c)^2 < P_{\rm{hT}}^{2} < 3$ (GeV/$c$)$^2$. The multiplicities are pres…

CERN LabComputerSystemsOrganization_COMPUTERSYSTEMIMPLEMENTATIONMULTIPLICITIESdimension: 3PT DEPENDENTComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISIONFOS: Physical sciencesComputerApplications_COMPUTERSINOTHERSYSTEMStarget: isoscalarmuon deuteron: deep inelastic scattering[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]nucl-extransverse momentum dependencehadron: transverse momentumSIDISCOMPASSGeneralLiterature_MISCELLANEOUSHigh Energy Physics - Experimentscaling: BjorkenSubatomär fysikcharged particle: multiplicityHigh Energy Physics - Experiment (hep-ex)[ PHYS.HEXP ] Physics [physics]/High Energy Physics - Experiment [hep-ex]mass: hadronicSubatomic Physics[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Nuclear Physics - Experiment[ PHYS.NEXP ] Physics [physics]/Nuclear Experiment [nucl-ex]Nuclear Experiment (nucl-ex)quantum chromodynamics: perturbation theoryNuclear ExperimentNuclear ExperimentDIShep-exhadron: multiplicityeffect: nonperturbativeperturbation theory: higher-orderCERN SPSphoton: energysemi-inclusive reactionComputingMethodologies_PATTERNRECOGNITIONkinematicsDIS; SIDIS; MULTIPLICITIES; PT DEPENDENTHigh Energy Physics::ExperimentParticle Physics - Experimentexperimental resultsphoton: virtual
researchProduct